Vaxcyte, Inc.
PCVX stock score: 48/100
$63.23 · -4.53% · Scored Oct 21, 2026
- Technical
- 65
- Fundamental
- 32
- News
- 41
The reading
Vaxcyte (PCVX) scores 48 out of 100, which reads weak, higher than 57% of Healthcare stocks and 37% of the 4,166 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 65, fundamentals 32.
Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Return on Equity (ROE) at 0 weighs the most against it.
On the daily chart, trend-following indicators average 61 and contrarian oscillators 51.
News sentiment is neutral at 41; it is shown, not counted in the composite.
Since Jul 25, 2026 the composite has ranged from 43 to 70, and it is down 21 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward PCVX’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
32Pulling it up
- Quick Ratio100
Quick ratio measures a company's ability to meet short-term obligations with liquid assets.
- Price Target100
Price target score compares the current stock price to analyst consensus targets.
- Fund Ownership100
Fund ownership tracks institutional investor holdings and changes.
Holding it back
- Return on Equity (ROE)0
Return on Equity (ROE) measures how efficiently a company generates profits from shareholder equity.
- Return on Assets (ROA)0
Return on Assets (ROA) shows how efficiently a company uses its assets to generate profit.
- Earnings Growth (Quarterly)1
Quarterly earnings growth measures profit increase versus the prior-year quarter.
29 weighted scorers; 12 had no data today and are left out rather than counted as zero.
Technical · daily
62Pulling it up
- 52-Week Change100
The price change over the last 52 weeks.
- Performance vs SPY97
Performance versus SPY compares the stock's returns to the S&P 500 index.
- S&P 500 52W Comparison90
S&P 500 52-week comparison evaluates the stock's annual performance relative to the broader market.
Holding it back
- Candlestick Patterns0
Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.
- VWAP0
Volume Weighted Average Price (VWAP) shows the average price weighted by volume.
- Parabolic SAR (PSAR)0
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
62 weighted scorers; 3 had no data today and are left out rather than counted as zero.
News · shown, not counted
- Global News
- 41
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 37 | 1 |
| Daily | 62 | 3 |
| Weekly | 69 | 2 |
| Monthly | 69 | 2 |
| Quarterly | 76 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 21, 2026 | 48 |
| Oct 20, 2026 | 50 |
| Oct 19, 2026 | 48 |
| Oct 18, 2026 | 48 |
| Oct 17, 2026 | 48 |
| Oct 16, 2026 | 48 |
| Oct 15, 2026 | 49 |
| Oct 14, 2026 | 50 |
| Oct 13, 2026 | 50 |
| Oct 12, 2026 | 51 |
| Oct 11, 2026 | 51 |
| Oct 10, 2026 | 51 |
| Oct 9, 2026 | 51 |
| Oct 8, 2026 | 50 |
| Oct 7, 2026 | 50 |
| Oct 6, 2026 | 50 |
| Oct 5, 2026 | 51 |
| Oct 4, 2026 | 43 |
| Oct 3, 2026 | 43 |
| Oct 2, 2026 | 45 |
| Oct 1, 2026 | 47 |
| Sep 30, 2026 | 45 |
| Sep 29, 2026 | 46 |
| Sep 28, 2026 | 46 |
| Sep 27, 2026 | 44 |
| Sep 26, 2026 | 44 |
| Sep 25, 2026 | 44 |
| Sep 24, 2026 | 46 |
| Sep 23, 2026 | 47 |
| Sep 22, 2026 | 48 |
| Sep 21, 2026 | 47 |
| Sep 20, 2026 | 46 |
| Sep 19, 2026 | 46 |
| Sep 18, 2026 | 46 |
| Sep 17, 2026 | 50 |
| Sep 16, 2026 | 47 |
| Sep 15, 2026 | 48 |
| Sep 14, 2026 | 48 |
| Sep 13, 2026 | 48 |
| Sep 12, 2026 | 48 |
| Sep 11, 2026 | 47 |
| Sep 10, 2026 | 47 |
| Sep 9, 2026 | 47 |
| Sep 8, 2026 | 49 |
| Sep 7, 2026 | 49 |
| Sep 6, 2026 | 48 |
| Sep 5, 2026 | 49 |
| Sep 4, 2026 | 48 |
| Sep 3, 2026 | 51 |
| Sep 2, 2026 | 50 |
| Sep 1, 2026 | 50 |
| Aug 31, 2026 | 49 |
| Aug 30, 2026 | 49 |
| Aug 29, 2026 | 49 |
| Aug 28, 2026 | 49 |
| Aug 27, 2026 | 49 |
| Aug 26, 2026 | 50 |
| Aug 25, 2026 | 50 |
| Aug 24, 2026 | 50 |
| Aug 23, 2026 | 51 |
| Aug 22, 2026 | 51 |
| Aug 20, 2026 | 56 |
| Aug 19, 2026 | 57 |
| Aug 18, 2026 | 55 |
| Aug 17, 2026 | 55 |
| Aug 16, 2026 | 54 |
| Aug 15, 2026 | 54 |
| Aug 14, 2026 | 54 |
| Aug 13, 2026 | 55 |
| Aug 12, 2026 | 56 |
| Aug 11, 2026 | 55 |
| Aug 10, 2026 | 55 |
| Aug 9, 2026 | 55 |
| Aug 8, 2026 | 55 |
| Aug 7, 2026 | 54 |
| Aug 6, 2026 | 54 |
| Aug 5, 2026 | 52 |
| Aug 3, 2026 | 50 |
| Aug 2, 2026 | 51 |
| Jul 31, 2026 | 70 |
| Jul 30, 2026 | 55 |
| Jul 29, 2026 | 50 |
| Jul 28, 2026 | 54 |
| Jul 27, 2026 | 55 |
| Jul 26, 2026 | 69 |
| Jul 25, 2026 | 69 |
Key facts
- Market cap
- $10.0B
- Sector
- Healthcare
- Industry
- Biotechnology
- Beta
- 1.23
- Risk grade (1–10)
- 7
- Next earnings
- Nov 3, 2026
Biotechnology peers
| Company | Market cap | Score |
|---|---|---|
| BMRN BioMarin Pharmaceutical | $10.7B | 46 |
| MDGL Madrigal Pharmaceuticals | $10.6B | 45 |
| TWST Twist Bioscience | $9.9B | 52 |
| KRYS Krystal Biotech | $9.5B | 66 |
| KYMR Kymera Therapeutics | $9.3B | 52 |
| IBRX ImmunityBio | $9.2B | 53 |
Questions
What is PCVX's stock score today?
PCVX scores 48/100 (Weak) as of Oct 21, 2026: technical 65, fundamental 32, and news sentiment 41, which is shown but not counted. Scores are recomputed every night.
Is PCVX a buy?
The score is not a buy or sell recommendation. A 48 says the technical and fundamental signals we measure lean weak today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the PCVX score calculated?
91 weighted scorers feed it today: 29 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.